Ingavirin Completed Phase 4 Trials for Respiratory Infections, Acute / Influenza, Human / Common Cold Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03154515Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults